Bottom line
FHCCX vs XLV: the short answer
FHCCX (Fidelity Advisor Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.
But FHCCX is far broader, holding 154 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
XLV is cheaper at 0.08% vs 1.71% — a difference of $163 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +2.8% for FHCCX (reporting dates differ).
Updated Nov 19, 2026
FHCCX vs XLV side by side
| FHCCX | XLV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.71% | 0.08% |
| Annual cost per $10k | $171 | $8 |
| 10-yr cost on $10k (prospectus) | $1,821 | $103 |
| Max front load | — | None |
| 12b-1 fee | 1% | 0.02% |
| 1-yr return | +12.5% | +14.5% |
| 5-yr return (annualized) | +2.8% | +8.1% |
| 10-yr return (annualized) | +7.6% | +9.8% |
| Best quarter | +21.3% | +14.5% |
| Worst quarter | −15.0% | −12.7% |
| Net assets (fund) | $3.1B | $40.6B |
| Number of holdings | 154 | 65 |
| Portfolio turnover | 74% | 2% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of FHCCX's top 25 holdings also appear in XLV's top 25.
| Holding | FHCCX | XLV |
|---|---|---|
| ELI LILLY and CO | 7.66% | 16.51% |
| Danaher Corp | 6.75% | 2.09% |
| Thermo Fisher Scientific Inc | 6.31% | 3.24% |
| Unitedhealth Group Inc | 4.17% | 6.57% |
| JOHNSON and JOHNSON | 3.78% | 10.64% |
| Abbvie Inc | 3.62% | 7.74% |
| MERCK and CO INC | 2.09% | 5.52% |
| Cvs Health Corp | 1.29% | 2.30% |
| Gilead Sciences Inc | 1.25% | 2.73% |
| Boston Scientific Corp | 1.23% | 1.10% |
Source: SEC Form N-PORT
FHCCX top 10
- ELI LILLY and CO — 7.66%
- Danaher Corp — 6.75%
- Thermo Fisher Scientific Inc — 6.31%
- Unitedhealth Group Inc — 4.17%
- JOHNSON and JOHNSON — 3.78%
- Abbvie Inc — 3.62%
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- MERCK and CO INC — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between FHCCX and XLV?
Which is cheaper, FHCCX or XLV?
Should I own both FHCCX and XLV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.